The Medical Travel Company (TMTC), a UK- and India-based medical travel startup, has snapped up a $4.5 million investment. The round was led by Nexus Venture Partners, with participation from 4CAST, an athlete-led collective and investment group cofounded by England cricket stars Ben Stokes and Jofra Archer, along with Indian batsman KL Rahul. The company has not disclosed its valuation.

The seed funding will reimagine the $100 billion global medical tourism market, starting with the UK. It plans to expand its UK clinical partnerships, strengthen patient pathways, and scale its technology infrastructure to securely manage medical data.

In addition to this, the company has launched the world’s first post-surgery insurance, protecting patients after returning home from treatment in India. 

Addresses a pain point in the medical travel industry

TMTC is tackling one of healthcare’s biggest pain points: long waitlists and unaffordable private care. As of mid-2025, more than 7.7 million UK patients are waiting for elective surgeries in areas like orthopaedics, IVF, and dental procedures. Many are turning to medical tourism, with over 500,000 UK residents reportedly travelling abroad annually for faster and more affordable treatment.

However, the existing system is fragmented, opaque, and risky. Patients often struggle with confusing pricing, inconsistent clinical quality, and a lack of post-surgery care once they return home. TMTC aims to change that by offering a full-stack, UK-doctor-led medical travel platform that ensures transparency, safety, and continuity of care.

Founders with proven credentials

TMTC was founded in 2024 by Sahil Jain and Ankit Mehrotra, the duo who built and sold Dineout, one of India’s major consumer-tech successes, acquired by Swiggy in 2022 for $200 million. 

He is a serial entrepreneur, TEDx speaker, and CFA charter holder. He spent the last decade building disruptive platforms across industries, from dining to healthcare, with The Medical Travel Company. Before entrepreneurship, he spent 10 years in London and worked with BNP Paribas (Investment Banking and Wealth Management) and also earned my CFA charter in 2011. 

In 2012, Sahil also co-founded Dineout with three close friends, scaling from zero to India’s largest dining out platform, serving over 3 million diners every month across 17 cities. At Dineout, he led TMTC’s push into B2B tech, acquiring and scaling SaaS products (inResto and Torqus) that now drive over 7,000+ restaurants worldwide. 

What market problem does it tackle?

In a discussion with TFN, TMTC stated that post-COVID, healthcare access in the developed world is broken, unequal and very expensive. The UK is facing an unprecedented challenge with nearly 8M people on NHS waiting lists, often waiting months or years for basic procedures like hip replacements, cataract surgery, or cancer treatment.

With very high private healthcare costs and with less than 13% of the population having insurance, people are left with no choice but to wait or travel abroad for treatment. The US is facing similar challenges with very high costs and insurance gaps. Canada also has massive waitlists. These problems will continue to grow due to an ageing population, systematic underfunding of public healthcare systems over the years and rising cost of private healthcare.

This has led to massive growth in Global Medical tourism. It is estimated to be already approximately $120B in 2024 and is projected to grow to roughly $300B by 2030. However, even for those willing to travel for care, the current medical tourism experience is unregulated, fragmented, and lacks transparency, with limited follow-up care upon the patient’s return to their home country, and is emotionally and logistically very stressful.

The company stated, “We are solving the trust, access, and coordination gap in cross-border healthcare by building a UK-INDIA corridor, to begin with, which tackles the NHS waitlist crisis by enabling UK patients to access high-quality, affordable surgeries in India. We focus on elective procedures like orthopaedics, gynaecology, IVF, dental, and aesthetics.” 

First-of-Its-kind insurance innovation

What truly sets TMTC apart is its world-first post-surgery insurance policy for international patients. This 12-month coverage is valid back in the UK and offers treatment at a network of private hospitals should complications arise. The platform offers fast-track, cost-effective, and high-quality medical solutions while maintaining UK-standard protocols and comprehensive aftercare services. No one else is offering this end-to-end full-stack service that we are offering.

TMTC also ensures care is delivered in globally accredited hospitals (JCI, NABH), with internationally trained doctors, and that UK physicians remain engaged throughout the process. Patients receive complete medical records for continuity of care and benefit from concierge-style, end-to-end management for a seamless, stress-free experience.

The company claims that TMTC is redefining what international patient care looks like with not just logistics, but quality, trust, and safety across borders.

Future plans

“Medical Tourism is a $100 billion global industry which is fragmented and unorganised. We have built a clinician-led end-to-end corridor from the UK to India for medical procedures. Over the next 3-5 years, we plan to expand our model to other geographies facing similar challenges, including the US, Canada, Australia and the rest of Europe and build a safe and trusted corridor for medical tourism, not just to India but to other medical tourism destinations as well,” stated TMTC.

Pratik Poddar, Partner at Nexus Venture Partners, said: “The medical tourism market holds immense untapped value, and The Medical Travel Company’s full-stack model is the key to unlocking it. India has long been a leading medical frontier, with world-class practitioners and cutting-edge technology; it’s about time this excellence is made globally accessible.”

Ben Stokes, founder of 4CAST and captain of the England Test team, said: “When we first started 4CAST in 2021, we wanted our collective of athletes to be able to partner with innovative businesses and great founders. We feel we have done so here, and we are excited to back Ankit and Sahil and look forward to supporting their journey ahead with TMTC.”

Jofra Archer, 4CAST cofounder and England bowler, added: “From my time playing in the IPL and touring India with England, I’ve always found the medical care and support there to be excellent. We invested because The Medical Travel Company is building a proper bridge for patients, with transparency and professional oversight that really gives peace of mind.”